Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Other Working Capital Changes (2017 - 2026)

Kiniksa Pharmaceuticals International filings provide 6 years of Other Working Capital Changes readings, the most recent being -$993000.0 for Q1 2026.

  • On a quarterly basis, Other Working Capital Changes fell 16.55% to -$993000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $22.3 million, a 19.69% increase, with the full-year FY2025 number at $22.5 million, up 14.99% from a year prior.
  • Other Working Capital Changes hit -$993000.0 in Q1 2026 for Kiniksa Pharmaceuticals International, down from $9.8 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $17.0 million in Q3 2024 to a low of -$4.7 million in Q2 2023.
  • Median Other Working Capital Changes over the past 5 years was $33000.0 (2024), compared with a mean of $2.5 million.
  • The widest YoY moves for Other Working Capital Changes: up 665700.0% in 2023, down 42927.27% in 2023.
  • Kiniksa Pharmaceuticals International's Other Working Capital Changes stood at $19000.0 in 2022, then soared by 13447.37% to $2.6 million in 2023, then rose by 18.14% to $3.0 million in 2024, then surged by 221.57% to $9.8 million in 2025, then crashed by 110.15% to -$993000.0 in 2026.
  • The last three reported values for Other Working Capital Changes were -$993000.0 (Q1 2026), $9.8 million (Q4 2025), and $507000.0 (Q3 2025) per Business Quant data.